dry eye disease
Aldeyra faces FDA rejection risk for dry eye drug due to review issues
Anika Sharma
Aldeyra Therapeutics confronts a daunting situation as regulatory concerns cast doubt on the future of its dry eye disease medication, ...
Aldeyra Therapeutics confronts a daunting situation as regulatory concerns cast doubt on the future of its dry eye disease medication, ...